European Journal of Dermatology
MENUExpert opinion: defining response to omalizumab in patients with chronic spontaneous urticaria Volume 27, numéro 5, September-October 2017
Citer cet article
Citation de l'article, à la forme « Vancouver » :
Marta Ferrer, Isabelle Boccon-Gibod, Margarida Gonçalo, Hüseyin Serhat İnalöz, André Knulst, Hilde Lapeere, Anchala Parthasaradhi, Georg Stingl, Anna Tagka, Fernando Valenzuela, Jensen Yeung, Simon Francis Thomsen. Expert opinion: defining response to omalizumab in patients with chronic spontaneous urticaria. European Journal of Dermatology. 2017;27(5):455-463. doi:10.1684/ejd.2017.3085